EXICURE INC
For the period ended Sep 30, 2023. Filed May 16, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2023 · Filed May 16, 2024
XCUR$1.08+21.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity
(in thousands, except shares)
| Common Stock | |||||
|---|---|---|---|---|---|
| Shares | $ | Additional Paid-in- Capital | Accumulated Deficit | Total Stockholders' Equity | |
| Balance at January 1, 2023 | 4,965,901 | $— | $187,571 | $(172,649) | $14,922 |
| Equity-based compensation | — | — | 308 | — | 308 |
| Reclassification of common stock warrants to liability | — | — | (800) | — | (800) |
| Vesting of restricted stock units and related repurchases | 5,561 | 1 | (2) | — | (1) |
| Issuance of common stock, net | 3,400,000 | — | 4,597 | — | 4,597 |
| Net loss | — | — | — | (4,407) | (4,407) |
| Balance at March 31, 2023 | 8,371,462 | $1 | $191,674 | $(177,056) | $14,619 |
| Equity-based compensation | — | — | 969 | — | 969 |
| Vesting of restricted stock units and related repurchases | 276,845 | — | (119) | — | (119) |
| Net loss | — | — | — | (5,764) | (5,764) |
| Balance at June 30, 2023 | 8,648,307 | $1 | $192,524 | $(182,820) | $9,705 |
| Equity-based compensation | — | — | 50 | — | 50 |
| Vesting of restricted stock units and related repurchases | 2,208 | — | (1) | — | (1) |
| Net loss | — | — | — | (5,256) | (5,256) |
| Balance at September 30, 2023 | 8,650,515 | $1 | $192,573 | $(188,076) | $4,498 |
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(in thousands, except shares)
| Common Stock | ||||||
|---|---|---|---|---|---|---|
| Shares | $ | Additional Paid-in- Capital | Accumulated Deficit | Accumulated Other Comprehensive Income | Total Stockholders' Equity | |
| Balance at January 1, 2022 | 3,626,073 | $— | $181,301 | $(170,067) | $(2) | $11,232 |
| Exercise of common stock warrants | 466,666 | — | 14 | — | — | 14 |
| Equity-based compensation | — | — | 342 | — | — | 342 |
| Vesting of restricted stock units and related repurchases | 324 | — | (1) | — | — | (1) |
| Other comprehensive loss, net | — | — | — | — | (3) | (3) |
| Net loss | — | — | — | (8,348) | — | (8,348) |
| Balance at March 31, 2022 | 4,093,063 | $— | $181,656 | $(178,415) | $(5) | $3,236 |
| Exercise of options | 124 | — | 1 | — | — | 1 |
| Equity-based compensation | — | — | 507 | — | — | 507 |
| Vesting of restricted stock units and related repurchases | 324 | — | (1) | — | — | (1) |
| Issuance of common stock-ESPP | 1,351 | — | 4 | — | — | 4 |
| Issuance of common stock and warrants | 867,369 | — | 4,886 | — | — | 4,886 |
| Net loss | — | — | — | (7,470) | — | (7,470) |
| Balance at June 30, 2022 | 4,962,231 | $— | $187,053 | $(185,885) | $(5) | $1,163 |
| Equity-based compensation | — | — | 292 | — | — | 292 |
| Vesting of restricted stock units and related repurchases | 2,082 | $— | $(2) | $— | $— | $(2) |
| Other comprehensive loss, net | — | $— | $— | $— | $4 | $4 |
| Net loss | — | $— | $— | $(5,160) | $— | $(5,160) |
| Balance at September 30, 2022 | 4,964,313 | $— | $187,343 | $(191,045) | $(1) | $(3,703) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.